Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.031 | 0.7 |
mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.024 | 0.7 |
mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.7 |
mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.7 |
mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |